Abstract
dc:description.abstractValid surrogate endpoints can make clinical trials more efficient, allowing for more trials to be conducted and more rapid development of effective treatments. Identifying useful surrogates is a statistically challenging but extremely valuable endeavor. This work develops statistical methods for the evaluation and comparison of biomarkers as correlates of protection (CoP). Methods herein were developed with a focus on a time-to-event clinical endpoint and possible time-varying effects of treatment, an important and thus far neglected topic is CoP evaluation. We propose a novel Weibull model and three methods of estimation for use in CoP evaluation; simulations and real data examples demonstrate the characteristics of these methods.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Gabriel, Erin Evelyn
- Advisor dc:contributor.advisor
-
- Gilbert, Peter B
Subjects
dc:subject × 1Rights
dc:rights- Statement dc:rights
-
- Copyright is held by the individual authors.
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1773/21887